An Open Letter to Our Community By Andreas Scherer, PhD President & CEO Going back in time to the beginning of this year, it would have been difficult to imagine what our world would look like as of June 2020. Things changed quickly. While we are still in the midst of the COVID-19 pandemic, the senseless killing of George Floyd triggered social unrest here in the USA that points to deeper underlying issues in our society... Read More
Golden Helix’s 2020 T-Shirt Competition Begins By Delaina Hawkins Director of Marketing It’s everyone’s favorite time of the year; Golden Helix’s Annual T-Shirt Design Competition is starting! Here's how you can enter to win one of our cash prizes:
- Draw it out or write it down; we accept either illustrated or written designs
- Email your designs to marketing@goldenhelix.com by August 25th
- Golden Helix will select three winners and notify them by August 27th
Learn more about the contest here
Featured in Clinical OMICs: Enabling Precision Medicine with Cutting-Edge NGS Technologies By Andreas Scherer, PhD President & CEO It is an honor to be featured in the Clinical OMICs May/June 2020 issue in a Q&A with the Editor discussing the past, present, and future of Golden Helix. In this article, I detail our most significant success throughout the past five years, how our products differentiate Golden Helix in the market, and our most significant opportunities in the next five years... Read More
Updates to Default Transcripts and Gene Preferences in VarSeq By Gabe Rudy VP of Product & Engineering An under-appreciated area of complexity when looking into the field of genetics from the outside can be found in genes and transcripts. Alternative splicing allows eukaryotic species to have a wonderfully powerful genetic code, resulting in multiple protein isoforms being encoded in a single section of DNA. But when it comes to variant interpretation, different transcripts can result in widely different predicted impacts... Read More |